Drug-Drug Interaction Prediction: a Purely SMILES Based Approach

2021 IEEE International Conference on Big Data (Big Data)

A drug-drug interaction (DDI) occurs when a drug is combined with other drug(s). DDIs have the potential to obstruct, increase, or diminish the intended impact of a drug or, in the worst-case scenario, induce an undesirable side effect. While it is critical to discover DDIs during clinical trials, it is impractical and expensive to detect all possible DDIs for a drug. Although several computational approaches for this problem have been developed, many of these methods need external biomedical knowledge that makes them difficult to generalize to drugs in early development phase. In this paper, we propose a novel method for predicting DDIs based on the vital chemical substructure of drugs extracted from their SMILES strings. We construct a graph that connects drugs based on their common functional chemical substructures. Furthermore, we apply different well-known graph neural network (GNN) methods to generate drug embeddings. Drug embeddings of individual drugs are concatenated to generate features of drug pairs. Finally, drug pair features are fed to different machine learning (ML) classifiers for DDI prediction. We evaluate our model on DrugBank dataset. Our result shows promising results and our model outperforms a baseline model based on different DDI representation creation methods.